Pneumonia Clinical Trials Pneumonia RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Chinese Hospital Acquired Pneumonia Collaboration Network: Epidemiology, Diagnosis and Treatment
Conditions:   Hospital-acquired Pneumonia;   Antibiotic Resistant Infection Intervention:   Other: prognosis status Sponsor:   Ruijin Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years
Conditions:   Influenza;   Community-acquired Pneumonia;   Cardiovascular Events Interventions:   Biological: Adjuvanted Quadrivalent Inactivated Influenza Vaccine (aIIV4);   Biological: High-Dose Quadrivalent Inactivated Influenza Vaccine (HD-IIV4) Sponsors:   Kaiser Permanente;   Seqirus Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Chinese Hospital Acquired Pneumonia Collaboration Network: Epidemiology, Diagnosis and Treatment
Conditions:   Hospital-acquired Pneumonia;   Antibiotic Resistant Infection Intervention:   Other: prognosis status Sponsor:   Ruijin Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years
Conditions:   Influenza;   Community-acquired Pneumonia;   Cardiovascular Events Interventions:   Biological: Adjuvanted Quadrivalent Inactivated Influenza Vaccine (aIIV4);   Biological: High-Dose Quadrivalent Inactivated Influenza Vaccine (HD-IIV4) Sponsors:   Kaiser Permanente;   Seqirus Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Chinese Hospital Acquired Pneumonia Collaboration Network: Epidemiology, Diagnosis and Treatment
Conditions:   Hospital-acquired Pneumonia;   Antibiotic Resistant Infection Intervention:   Other: prognosis status Sponsor:   Ruijin Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years
Conditions:   Influenza;   Community-acquired Pneumonia;   Cardiovascular Events Interventions:   Biological: Adjuvanted Quadrivalent Inactivated Influenza Vaccine (aIIV4);   Biological: High-Dose Quadrivalent Inactivated Influenza Vaccine (HD-IIV4) Sponsors:   Kaiser Permanente;   Seqirus Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Chinese Hospital Acquired Pneumonia Collaboration Network: Epidemiology, Diagnosis and Treatment
Conditions:   Hospital-acquired Pneumonia;   Antibiotic Resistant Infection Intervention:   Other: prognosis status Sponsor:   Ruijin Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years
Conditions:   Influenza;   Community-acquired Pneumonia;   Cardiovascular Events Interventions:   Biological: Adjuvanted Quadrivalent Inactivated Influenza Vaccine (aIIV4);   Biological: High-Dose Quadrivalent Inactivated Influenza Vaccine (HD-IIV4) Sponsors:   Kaiser Permanente;   Seqirus Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Chinese Hospital Acquired Pneumonia Collaboration Network: Epidemiology, Diagnosis and Treatment
Conditions:   Hospital-acquired Pneumonia;   Antibiotic Resistant Infection Intervention:   Other: prognosis status Sponsor:   Ruijin Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years
Conditions:   Influenza;   Community-acquired Pneumonia;   Cardiovascular Events Interventions:   Biological: Adjuvanted Quadrivalent Inactivated Influenza Vaccine (aIIV4);   Biological: High-Dose Quadrivalent Inactivated Influenza Vaccine (HD-IIV4) Sponsors:   Kaiser Permanente;   Seqirus Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Chinese Hospital Acquired Pneumonia Collaboration Network: Epidemiology, Diagnosis and Treatment
Conditions:   Hospital-acquired Pneumonia;   Antibiotic Resistant Infection Intervention:   Other: prognosis status Sponsor:   Ruijin Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years
Conditions:   Influenza;   Community-acquired Pneumonia;   Cardiovascular Events Interventions:   Biological: Adjuvanted Quadrivalent Inactivated Influenza Vaccine (aIIV4);   Biological: High-Dose Quadrivalent Inactivated Influenza Vaccine (HD-IIV4) Sponsors:   Kaiser Permanente;   Seqirus Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Chinese Hospital Acquired Pneumonia Collaboration Network: Epidemiology, Diagnosis and Treatment
Conditions:   Hospital-acquired Pneumonia;   Antibiotic Resistant Infection Intervention:   Other: prognosis status Sponsor:   Ruijin Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials